Maintenance olaparib plus bevacizumab (bev) after platinum-based chemotherapy plus bev in patients (pts) with newly diagnosed advanced high-grade ovarian cancer (HGOC): Efficacy by timing of surgery and residual tumor status in the Phase III PAOLA-1 trial
Authors:
- C. GrimmCGC. Grimm
- C. CropetCCC. Cropet
- I. Ray-CoquardIRI. Ray-Coquard
- 1 October 2020
- journal article
- abstracts
- Published by Elsevier in Gynecologic Oncology
- Vol. 159, 19